id	sid	tid	token	lemma	pos
cord-327264-j0efi5vc	1	1	key	key	JJ
cord-327264-j0efi5vc	2	1	:	:	:
cord-327264-j0efi5vc	2	2	cord-327264-j0efi5vc	cord-327264-j0efi5vc	NNP
cord-327264-j0efi5vc	2	3	authors	author	NNS
cord-327264-j0efi5vc	2	4	:	:	:
cord-327264-j0efi5vc	2	5	Waterer	Waterer	NNP
cord-327264-j0efi5vc	2	6	,	,	,
cord-327264-j0efi5vc	2	7	Grant	Grant	NNP
cord-327264-j0efi5vc	2	8	title	title	NN
cord-327264-j0efi5vc	2	9	:	:	:
cord-327264-j0efi5vc	2	10	Respiratory	respiratory	JJ
cord-327264-j0efi5vc	2	11	infections	infection	NNS
cord-327264-j0efi5vc	2	12	in	in	IN
cord-327264-j0efi5vc	2	13	the	the	DT
cord-327264-j0efi5vc	2	14	Asia‐Pacific	asia‐pacific	JJ
cord-327264-j0efi5vc	2	15	region	region	NN
cord-327264-j0efi5vc	2	16	date	date	NN
cord-327264-j0efi5vc	2	17	:	:	:
cord-327264-j0efi5vc	2	18	2017	2017	CD
cord-327264-j0efi5vc	2	19	-	-	HYPH
cord-327264-j0efi5vc	2	20	05	05	CD
cord-327264-j0efi5vc	2	21	-	-	HYPH
cord-327264-j0efi5vc	2	22	24	24	CD
cord-327264-j0efi5vc	2	23	journal	journal	NN
cord-327264-j0efi5vc	2	24	:	:	:
cord-327264-j0efi5vc	2	25	Respirology	Respirology	NNP
cord-327264-j0efi5vc	2	26	DOI	DOI	NNP
cord-327264-j0efi5vc	2	27	:	:	:
cord-327264-j0efi5vc	2	28	10.1111	10.1111	CD
cord-327264-j0efi5vc	2	29	/	/	SYM
cord-327264-j0efi5vc	2	30	resp.13077	resp.13077	NNP
cord-327264-j0efi5vc	2	31	sha	sha	NNP
cord-327264-j0efi5vc	2	32	:	:	:
cord-327264-j0efi5vc	3	1	15577416f764f2c1cb30a32a6ebac818d3b38a00	15577416f764f2c1cb30a32a6ebac818d3b38a00	CD
cord-327264-j0efi5vc	3	2	doc_id	doc_id	CD
cord-327264-j0efi5vc	3	3	:	:	:
cord-327264-j0efi5vc	3	4	327264	327264	CD
cord-327264-j0efi5vc	3	5	cord_uid	cord_uid	NNS
cord-327264-j0efi5vc	3	6	:	:	:
cord-327264-j0efi5vc	4	1	j0efi5vc	j0efi5vc	NNP
cord-327264-j0efi5vc	4	2	nan	nan	NNP
cord-327264-j0efi5vc	5	1	I	-PRON-	PRP
cord-327264-j0efi5vc	5	2	frequently	frequently	RB
cord-327264-j0efi5vc	5	3	tell	tell	VBP
cord-327264-j0efi5vc	5	4	young	young	JJ
cord-327264-j0efi5vc	5	5	prospective	prospective	JJ
cord-327264-j0efi5vc	5	6	research	research	NN
cord-327264-j0efi5vc	5	7	students	student	NNS
cord-327264-j0efi5vc	5	8	that	that	IN
cord-327264-j0efi5vc	5	9	respiratory	respiratory	JJ
cord-327264-j0efi5vc	5	10	infections	infection	NNS
cord-327264-j0efi5vc	5	11	are	be	VBP
cord-327264-j0efi5vc	5	12	a	a	DT
cord-327264-j0efi5vc	5	13	great	great	JJ
cord-327264-j0efi5vc	5	14	area	area	NN
cord-327264-j0efi5vc	5	15	to	to	TO
cord-327264-j0efi5vc	5	16	develop	develop	VB
cord-327264-j0efi5vc	5	17	expertise	expertise	NN
cord-327264-j0efi5vc	5	18	in	in	IN
cord-327264-j0efi5vc	5	19	because	because	IN
cord-327264-j0efi5vc	5	20	unlike	unlike	IN
cord-327264-j0efi5vc	5	21	cancer	cancer	NN
cord-327264-j0efi5vc	5	22	or	or	CC
cord-327264-j0efi5vc	5	23	cardiovascular	cardiovascular	JJ
cord-327264-j0efi5vc	5	24	disease	disease	NN
cord-327264-j0efi5vc	5	25	they	-PRON-	PRP
cord-327264-j0efi5vc	5	26	can	can	MD
cord-327264-j0efi5vc	5	27	be	be	VB
cord-327264-j0efi5vc	5	28	guaranteed	guarantee	VBN
cord-327264-j0efi5vc	5	29	the	the	DT
cord-327264-j0efi5vc	5	30	problem	problem	NN
cord-327264-j0efi5vc	5	31	will	will	MD
cord-327264-j0efi5vc	5	32	not	not	RB
cord-327264-j0efi5vc	5	33	be	be	VB
cord-327264-j0efi5vc	5	34	solved	solve	VBN
cord-327264-j0efi5vc	5	35	and	and	CC
cord-327264-j0efi5vc	5	36	go	go	VB
cord-327264-j0efi5vc	5	37	away	away	RB
cord-327264-j0efi5vc	5	38	in	in	IN
cord-327264-j0efi5vc	5	39	their	-PRON-	PRP$
cord-327264-j0efi5vc	5	40	lifetime	lifetime	NN
cord-327264-j0efi5vc	5	41	.	.	.
cord-327264-j0efi5vc	6	1	The	the	DT
cord-327264-j0efi5vc	6	2	burden	burden	NN
cord-327264-j0efi5vc	6	3	of	of	IN
cord-327264-j0efi5vc	6	4	respiratory	respiratory	JJ
cord-327264-j0efi5vc	6	5	infectious	infectious	JJ
cord-327264-j0efi5vc	6	6	disease	disease	NN
cord-327264-j0efi5vc	6	7	is	be	VBZ
cord-327264-j0efi5vc	6	8	large	large	JJ
cord-327264-j0efi5vc	6	9	,	,	,
cord-327264-j0efi5vc	6	10	not	not	RB
cord-327264-j0efi5vc	6	11	only	only	RB
cord-327264-j0efi5vc	6	12	acutely	acutely	RB
cord-327264-j0efi5vc	6	13	,	,	,
cord-327264-j0efi5vc	6	14	but	but	CC
cord-327264-j0efi5vc	6	15	also	also	RB
cord-327264-j0efi5vc	6	16	due	due	IN
cord-327264-j0efi5vc	6	17	to	to	IN
cord-327264-j0efi5vc	6	18	their	-PRON-	PRP$
cord-327264-j0efi5vc	6	19	chronic	chronic	JJ
cord-327264-j0efi5vc	6	20	complications	complication	NNS
cord-327264-j0efi5vc	6	21	.	.	.
cord-327264-j0efi5vc	7	1	Lower	low	JJR
cord-327264-j0efi5vc	7	2	respiratory	respiratory	JJ
cord-327264-j0efi5vc	7	3	tract	tract	NN
cord-327264-j0efi5vc	7	4	infections	infection	NNS
cord-327264-j0efi5vc	7	5	remain	remain	VBP
cord-327264-j0efi5vc	7	6	the	the	DT
cord-327264-j0efi5vc	7	7	number	number	NN
cord-327264-j0efi5vc	7	8	one	one	CD
cord-327264-j0efi5vc	7	9	cause	cause	NN
cord-327264-j0efi5vc	7	10	of	of	IN
cord-327264-j0efi5vc	7	11	death	death	NN
cord-327264-j0efi5vc	7	12	in	in	IN
cord-327264-j0efi5vc	7	13	the	the	DT
cord-327264-j0efi5vc	7	14	developing	develop	VBG
cord-327264-j0efi5vc	7	15	world	world	NN
cord-327264-j0efi5vc	7	16	.	.	.
cord-327264-j0efi5vc	8	1	1	1	LS
cord-327264-j0efi5vc	9	1	In	in	IN
cord-327264-j0efi5vc	9	2	the	the	DT
cord-327264-j0efi5vc	9	3	developed	develop	VBN
cord-327264-j0efi5vc	9	4	world	world	NN
cord-327264-j0efi5vc	9	5	,	,	,
cord-327264-j0efi5vc	9	6	lower	low	JJR
cord-327264-j0efi5vc	9	7	respiratory	respiratory	JJ
cord-327264-j0efi5vc	9	8	tract	tract	NN
cord-327264-j0efi5vc	9	9	infections	infection	NNS
cord-327264-j0efi5vc	9	10	are	be	VBP
cord-327264-j0efi5vc	9	11	still	still	RB
cord-327264-j0efi5vc	9	12	the	the	DT
cord-327264-j0efi5vc	9	13	fifth	fifth	JJ
cord-327264-j0efi5vc	9	14	leading	leading	JJ
cord-327264-j0efi5vc	9	15	cause	cause	NN
cord-327264-j0efi5vc	9	16	of	of	IN
cord-327264-j0efi5vc	9	17	death	death	NN
cord-327264-j0efi5vc	9	18	.	.	.
cord-327264-j0efi5vc	10	1	1	1	LS
cord-327264-j0efi5vc	11	1	The	the	DT
cord-327264-j0efi5vc	11	2	increasing	increase	VBG
cord-327264-j0efi5vc	11	3	age	age	NN
cord-327264-j0efi5vc	11	4	of	of	IN
cord-327264-j0efi5vc	11	5	the	the	DT
cord-327264-j0efi5vc	11	6	general	general	JJ
cord-327264-j0efi5vc	11	7	population	population	NN
cord-327264-j0efi5vc	11	8	in	in	IN
cord-327264-j0efi5vc	11	9	most	most	JJS
cord-327264-j0efi5vc	11	10	countries	country	NNS
cord-327264-j0efi5vc	11	11	,	,	,
cord-327264-j0efi5vc	11	12	our	-PRON-	PRP$
cord-327264-j0efi5vc	11	13	ability	ability	NN
cord-327264-j0efi5vc	11	14	to	to	TO
cord-327264-j0efi5vc	11	15	keep	keep	VB
cord-327264-j0efi5vc	11	16	people	people	NNS
cord-327264-j0efi5vc	11	17	from	from	IN
cord-327264-j0efi5vc	11	18	succumbing	succumb	VBG
cord-327264-j0efi5vc	11	19	to	to	IN
cord-327264-j0efi5vc	11	20	chronic	chronic	JJ
cord-327264-j0efi5vc	11	21	organ	organ	NN
cord-327264-j0efi5vc	11	22	failure	failure	NN
cord-327264-j0efi5vc	11	23	and	and	CC
cord-327264-j0efi5vc	11	24	the	the	DT
cord-327264-j0efi5vc	11	25	ever	ever	RB
cord-327264-j0efi5vc	11	26	increasing	increase	VBG
cord-327264-j0efi5vc	11	27	array	array	NN
cord-327264-j0efi5vc	11	28	of	of	IN
cord-327264-j0efi5vc	11	29	immunosuppressant	immunosuppressant	JJ
cord-327264-j0efi5vc	11	30	drugs	drug	NNS
cord-327264-j0efi5vc	11	31	being	be	VBG
cord-327264-j0efi5vc	11	32	used	use	VBN
cord-327264-j0efi5vc	11	33	in	in	IN
cord-327264-j0efi5vc	11	34	a	a	DT
cord-327264-j0efi5vc	11	35	variety	variety	NN
cord-327264-j0efi5vc	11	36	of	of	IN
cord-327264-j0efi5vc	11	37	neoplastic	neoplastic	JJ
cord-327264-j0efi5vc	11	38	and	and	CC
cord-327264-j0efi5vc	11	39	immune	immune	JJ
cord-327264-j0efi5vc	11	40	diseases	disease	NNS
cord-327264-j0efi5vc	11	41	ensure	ensure	VBP
cord-327264-j0efi5vc	11	42	that	that	IN
cord-327264-j0efi5vc	11	43	there	there	EX
cord-327264-j0efi5vc	11	44	is	be	VBZ
cord-327264-j0efi5vc	11	45	an	an	DT
cord-327264-j0efi5vc	11	46	ever	ever	RB
cord-327264-j0efi5vc	11	47	increasing	increase	VBG
cord-327264-j0efi5vc	11	48	pool	pool	NN
cord-327264-j0efi5vc	11	49	of	of	IN
cord-327264-j0efi5vc	11	50	vulnerable	vulnerable	JJ
cord-327264-j0efi5vc	11	51	hosts	host	NNS
cord-327264-j0efi5vc	11	52	.	.	.
cord-327264-j0efi5vc	12	1	As	as	RB
cord-327264-j0efi5vc	12	2	well	well	RB
cord-327264-j0efi5vc	12	3	as	as	IN
cord-327264-j0efi5vc	12	4	host	host	NN
cord-327264-j0efi5vc	12	5	factors	factor	NNS
cord-327264-j0efi5vc	12	6	,	,	,
cord-327264-j0efi5vc	12	7	it	-PRON-	PRP
cord-327264-j0efi5vc	12	8	is	be	VBZ
cord-327264-j0efi5vc	12	9	the	the	DT
cord-327264-j0efi5vc	12	10	speed	speed	NN
cord-327264-j0efi5vc	12	11	of	of	IN
cord-327264-j0efi5vc	12	12	adaptation	adaptation	NN
cord-327264-j0efi5vc	12	13	of	of	IN
cord-327264-j0efi5vc	12	14	the	the	DT
cord-327264-j0efi5vc	12	15	pathogens	pathogen	NNS
cord-327264-j0efi5vc	12	16	that	that	WDT
cord-327264-j0efi5vc	12	17	makes	make	VBZ
cord-327264-j0efi5vc	12	18	it	-PRON-	PRP
cord-327264-j0efi5vc	12	19	most	most	RBS
cord-327264-j0efi5vc	12	20	likely	likely	JJ
cord-327264-j0efi5vc	12	21	that	that	IN
cord-327264-j0efi5vc	12	22	we	-PRON-	PRP
cord-327264-j0efi5vc	12	23	will	will	MD
cord-327264-j0efi5vc	12	24	not	not	RB
cord-327264-j0efi5vc	12	25	conquer	conquer	VB
cord-327264-j0efi5vc	12	26	death	death	NN
cord-327264-j0efi5vc	12	27	from	from	IN
cord-327264-j0efi5vc	12	28	respiratory	respiratory	JJ
cord-327264-j0efi5vc	12	29	infection	infection	NN
cord-327264-j0efi5vc	12	30	any	any	DT
cord-327264-j0efi5vc	12	31	time	time	NN
cord-327264-j0efi5vc	12	32	soon	soon	RB
cord-327264-j0efi5vc	12	33	.	.	.
cord-327264-j0efi5vc	13	1	While	while	IN
cord-327264-j0efi5vc	13	2	some	some	DT
cord-327264-j0efi5vc	13	3	progress	progress	NN
cord-327264-j0efi5vc	13	4	has	have	VBZ
cord-327264-j0efi5vc	13	5	been	be	VBN
cord-327264-j0efi5vc	13	6	made	make	VBN
cord-327264-j0efi5vc	13	7	in	in	IN
cord-327264-j0efi5vc	13	8	reducing	reduce	VBG
cord-327264-j0efi5vc	13	9	pneumococcal	pneumococcal	JJ
cord-327264-j0efi5vc	13	10	disease	disease	NN
cord-327264-j0efi5vc	13	11	with	with	IN
cord-327264-j0efi5vc	13	12	the	the	DT
cord-327264-j0efi5vc	13	13	newer	new	JJR
cord-327264-j0efi5vc	13	14	conjugate	conjugate	JJ
cord-327264-j0efi5vc	13	15	vaccines	vaccine	NNS
cord-327264-j0efi5vc	13	16	,	,	,
cord-327264-j0efi5vc	13	17	2	2	LS
cord-327264-j0efi5vc	13	18	there	there	EX
cord-327264-j0efi5vc	13	19	is	be	VBZ
cord-327264-j0efi5vc	13	20	evidence	evidence	NN
cord-327264-j0efi5vc	13	21	that	that	IN
cord-327264-j0efi5vc	13	22	the	the	DT
cord-327264-j0efi5vc	13	23	speed	speed	NN
cord-327264-j0efi5vc	13	24	of	of	IN
cord-327264-j0efi5vc	13	25	adaptation	adaptation	NN
cord-327264-j0efi5vc	13	26	(	(	-LRB-
cord-327264-j0efi5vc	13	27	as	as	IN
cord-327264-j0efi5vc	13	28	measured	measure	VBN
cord-327264-j0efi5vc	13	29	by	by	IN
cord-327264-j0efi5vc	13	30	the	the	DT
cord-327264-j0efi5vc	13	31	proportion	proportion	NN
cord-327264-j0efi5vc	13	32	of	of	IN
cord-327264-j0efi5vc	13	33	strains	strain	NNS
cord-327264-j0efi5vc	13	34	not	not	RB
cord-327264-j0efi5vc	13	35	covered	cover	VBN
cord-327264-j0efi5vc	13	36	by	by	IN
cord-327264-j0efi5vc	13	37	the	the	DT
cord-327264-j0efi5vc	13	38	vaccines	vaccine	NNS
cord-327264-j0efi5vc	13	39	)	)	-RRB-
cord-327264-j0efi5vc	13	40	is	be	VBZ
cord-327264-j0efi5vc	13	41	increasing	increase	VBG
cord-327264-j0efi5vc	13	42	.	.	.
cord-327264-j0efi5vc	14	1	[	[	-LRB-
cord-327264-j0efi5vc	14	2	3	3	CD
cord-327264-j0efi5vc	14	3	]	]	-RRB-
cord-327264-j0efi5vc	14	4	[	[	-LRB-
cord-327264-j0efi5vc	14	5	4	4	CD
cord-327264-j0efi5vc	14	6	]	]	-RRB-
cord-327264-j0efi5vc	14	7	[	[	-LRB-
cord-327264-j0efi5vc	14	8	5	5	CD
cord-327264-j0efi5vc	14	9	]	]	-RRB-
cord-327264-j0efi5vc	14	10	Adaptation	adaptation	NN
cord-327264-j0efi5vc	14	11	in	in	IN
cord-327264-j0efi5vc	14	12	other	other	JJ
cord-327264-j0efi5vc	14	13	pathogens	pathogen	NNS
cord-327264-j0efi5vc	14	14	is	be	VBZ
cord-327264-j0efi5vc	14	15	posing	pose	VBG
cord-327264-j0efi5vc	14	16	challenges	challenge	NNS
cord-327264-j0efi5vc	14	17	in	in	IN
cord-327264-j0efi5vc	14	18	multiple	multiple	JJ
cord-327264-j0efi5vc	14	19	areas	area	NNS
cord-327264-j0efi5vc	14	20	including	include	VBG
cord-327264-j0efi5vc	14	21	drug	drug	NN
cord-327264-j0efi5vc	14	22	-	-	HYPH
cord-327264-j0efi5vc	14	23	resistant	resistant	JJ
cord-327264-j0efi5vc	14	24	tuberculosis	tuberculosis	NN
cord-327264-j0efi5vc	14	25	,	,	,
cord-327264-j0efi5vc	14	26	pan	pan	NN
cord-327264-j0efi5vc	14	27	-	-	JJ
cord-327264-j0efi5vc	14	28	resistant	resistant	JJ
cord-327264-j0efi5vc	14	29	Gram	Gram	NNP
cord-327264-j0efi5vc	14	30	-	-	HYPH
cord-327264-j0efi5vc	14	31	negative	negative	JJ
cord-327264-j0efi5vc	14	32	pathogens	pathogen	NNS
cord-327264-j0efi5vc	14	33	and	and	CC
cord-327264-j0efi5vc	14	34	ever	ever	RB
cord-327264-j0efi5vc	14	35	increasing	increase	VBG
cord-327264-j0efi5vc	14	36	rates	rate	NNS
cord-327264-j0efi5vc	14	37	of	of	IN
cord-327264-j0efi5vc	14	38	community	community	NN
cord-327264-j0efi5vc	14	39	-	-	HYPH
cord-327264-j0efi5vc	14	40	acquired	acquire	VBN
cord-327264-j0efi5vc	14	41	methicillin	methicillin	NN
cord-327264-j0efi5vc	14	42	-	-	HYPH
cord-327264-j0efi5vc	14	43	resistant	resistant	JJ
cord-327264-j0efi5vc	14	44	Staphylococcus	Staphylococcus	NNP
cord-327264-j0efi5vc	14	45	aureus	aureus	NN
cord-327264-j0efi5vc	14	46	in	in	IN
cord-327264-j0efi5vc	14	47	many	many	JJ
cord-327264-j0efi5vc	14	48	Western	western	JJ
cord-327264-j0efi5vc	14	49	countries	country	NNS
cord-327264-j0efi5vc	14	50	.	.	.
cord-327264-j0efi5vc	15	1	Not	not	RB
cord-327264-j0efi5vc	15	2	only	only	RB
cord-327264-j0efi5vc	15	3	is	be	VBZ
cord-327264-j0efi5vc	15	4	there	there	EX
cord-327264-j0efi5vc	15	5	adaptation	adaptation	NN
cord-327264-j0efi5vc	15	6	of	of	IN
cord-327264-j0efi5vc	15	7	existing	exist	VBG
cord-327264-j0efi5vc	15	8	pathogens	pathogen	NNS
cord-327264-j0efi5vc	15	9	,	,	,
cord-327264-j0efi5vc	15	10	the	the	DT
cord-327264-j0efi5vc	15	11	progressive	progressive	JJ
cord-327264-j0efi5vc	15	12	encroachment	encroachment	NN
cord-327264-j0efi5vc	15	13	of	of	IN
cord-327264-j0efi5vc	15	14	humans	human	NNS
cord-327264-j0efi5vc	15	15	on	on	IN
cord-327264-j0efi5vc	15	16	other	other	JJ
cord-327264-j0efi5vc	15	17	habitats	habitat	NNS
cord-327264-j0efi5vc	15	18	has	have	VBZ
cord-327264-j0efi5vc	15	19	seen	see	VBN
cord-327264-j0efi5vc	15	20	the	the	DT
cord-327264-j0efi5vc	15	21	rise	rise	NN
cord-327264-j0efi5vc	15	22	of	of	IN
cord-327264-j0efi5vc	15	23	new	new	JJ
cord-327264-j0efi5vc	15	24	pathogens	pathogen	NNS
cord-327264-j0efi5vc	15	25	such	such	JJ
cord-327264-j0efi5vc	15	26	as	as	IN
cord-327264-j0efi5vc	15	27	coronaviruses	coronaviruse	NNS
cord-327264-j0efi5vc	15	28	causing	cause	VBG
cord-327264-j0efi5vc	15	29	severe	severe	JJ
cord-327264-j0efi5vc	15	30	acute	acute	JJ
cord-327264-j0efi5vc	15	31	respiratory	respiratory	JJ
cord-327264-j0efi5vc	15	32	syndrome	syndrome	NN
cord-327264-j0efi5vc	15	33	and	and	CC
cord-327264-j0efi5vc	15	34	Middle	Middle	NNP
cord-327264-j0efi5vc	15	35	East	East	NNP
cord-327264-j0efi5vc	15	36	respiratory	respiratory	JJ
cord-327264-j0efi5vc	15	37	syndrome	syndrome	NN
cord-327264-j0efi5vc	15	38	,	,	,
cord-327264-j0efi5vc	15	39	as	as	RB
cord-327264-j0efi5vc	15	40	well	well	RB
cord-327264-j0efi5vc	15	41	as	as	IN
cord-327264-j0efi5vc	15	42	novel	novel	JJ
cord-327264-j0efi5vc	15	43	influenza	influenza	NN
cord-327264-j0efi5vc	15	44	strains	strain	NNS
cord-327264-j0efi5vc	15	45	such	such	JJ
cord-327264-j0efi5vc	15	46	as	as	IN
cord-327264-j0efi5vc	15	47	H1N1	H1N1	NNP
cord-327264-j0efi5vc	15	48	09	09	CD
cord-327264-j0efi5vc	15	49	and	and	CC
cord-327264-j0efi5vc	15	50	the	the	DT
cord-327264-j0efi5vc	15	51	avian	avian	JJ
cord-327264-j0efi5vc	15	52	H5	H5	NNP
cord-327264-j0efi5vc	15	53	,	,	,
cord-327264-j0efi5vc	15	54	H7	H7	NNP
cord-327264-j0efi5vc	15	55	and	and	CC
cord-327264-j0efi5vc	15	56	H9	H9	NNP
cord-327264-j0efi5vc	15	57	strains	strain	NNS
cord-327264-j0efi5vc	15	58	.	.	.
cord-327264-j0efi5vc	16	1	With	with	IN
cord-327264-j0efi5vc	16	2	the	the	DT
cord-327264-j0efi5vc	16	3	notable	notable	JJ
cord-327264-j0efi5vc	16	4	exception	exception	NN
cord-327264-j0efi5vc	16	5	of	of	IN
cord-327264-j0efi5vc	16	6	H1N1	H1N1	NNP
cord-327264-j0efi5vc	16	7	09	09	CD
cord-327264-j0efi5vc	16	8	,	,	,
cord-327264-j0efi5vc	16	9	all	all	DT
cord-327264-j0efi5vc	16	10	of	of	IN
cord-327264-j0efi5vc	16	11	these	these	DT
cord-327264-j0efi5vc	16	12	viral	viral	JJ
cord-327264-j0efi5vc	16	13	infections	infection	NNS
cord-327264-j0efi5vc	16	14	are	be	VBP
cord-327264-j0efi5vc	16	15	associated	associate	VBN
cord-327264-j0efi5vc	16	16	with	with	IN
cord-327264-j0efi5vc	16	17	severe	severe	JJ
cord-327264-j0efi5vc	16	18	disease	disease	NN
cord-327264-j0efi5vc	16	19	and	and	CC
cord-327264-j0efi5vc	16	20	high	high	JJ
cord-327264-j0efi5vc	16	21	mortality	mortality	NN
cord-327264-j0efi5vc	16	22	rates	rate	NNS
cord-327264-j0efi5vc	16	23	.	.	.
cord-327264-j0efi5vc	17	1	In	in	IN
cord-327264-j0efi5vc	17	2	this	this	DT
cord-327264-j0efi5vc	17	3	series	series	NN
cord-327264-j0efi5vc	17	4	on	on	IN
cord-327264-j0efi5vc	17	5	respiratory	respiratory	JJ
cord-327264-j0efi5vc	17	6	infections	infection	NNS
cord-327264-j0efi5vc	17	7	in	in	IN
cord-327264-j0efi5vc	17	8	Respirology	Respirology	NNP
cord-327264-j0efi5vc	17	9	,	,	,
cord-327264-j0efi5vc	17	10	many	many	JJ
cord-327264-j0efi5vc	17	11	of	of	IN
cord-327264-j0efi5vc	17	12	the	the	DT
cord-327264-j0efi5vc	17	13	above	above	RB
cord-327264-j0efi5vc	17	14	-	-	HYPH
cord-327264-j0efi5vc	17	15	mentioned	mention	VBN
cord-327264-j0efi5vc	17	16	challenges	challenge	NNS
cord-327264-j0efi5vc	17	17	will	will	MD
cord-327264-j0efi5vc	17	18	be	be	VB
cord-327264-j0efi5vc	17	19	covered	cover	VBN
cord-327264-j0efi5vc	17	20	including	include	VBG
cord-327264-j0efi5vc	17	21	the	the	DT
cord-327264-j0efi5vc	17	22	burden	burden	NN
cord-327264-j0efi5vc	17	23	of	of	IN
cord-327264-j0efi5vc	17	24	disease	disease	NN
cord-327264-j0efi5vc	17	25	due	due	IN
cord-327264-j0efi5vc	17	26	to	to	IN
cord-327264-j0efi5vc	17	27	respiratory	respiratory	JJ
cord-327264-j0efi5vc	17	28	pathogens	pathogen	NNS
cord-327264-j0efi5vc	17	29	(	(	-LRB-
cord-327264-j0efi5vc	17	30	both	both	DT
cord-327264-j0efi5vc	17	31	acute	acute	JJ
cord-327264-j0efi5vc	17	32	and	and	CC
cord-327264-j0efi5vc	17	33	long	long	JJ
cord-327264-j0efi5vc	17	34	-	-	HYPH
cord-327264-j0efi5vc	17	35	term	term	NN
cord-327264-j0efi5vc	17	36	)	)	-RRB-
cord-327264-j0efi5vc	17	37	,	,	,
cord-327264-j0efi5vc	17	38	drug	drug	NN
cord-327264-j0efi5vc	17	39	-	-	HYPH
cord-327264-j0efi5vc	17	40	resistant	resistant	JJ
cord-327264-j0efi5vc	17	41	pathogens	pathogen	NNS
cord-327264-j0efi5vc	17	42	and	and	CC
cord-327264-j0efi5vc	17	43	newly	newly	RB
cord-327264-j0efi5vc	17	44	emerging	emerge	VBG
cord-327264-j0efi5vc	17	45	pathogens	pathogen	NNS
cord-327264-j0efi5vc	17	46	.	.	.
cord-327264-j0efi5vc	18	1	Other	other	JJ
cord-327264-j0efi5vc	18	2	reviews	review	NNS
cord-327264-j0efi5vc	18	3	will	will	MD
cord-327264-j0efi5vc	18	4	focus	focus	VB
cord-327264-j0efi5vc	18	5	on	on	IN
cord-327264-j0efi5vc	18	6	key	key	JJ
cord-327264-j0efi5vc	18	7	areas	area	NNS
cord-327264-j0efi5vc	18	8	such	such	JJ
cord-327264-j0efi5vc	18	9	as	as	IN
cord-327264-j0efi5vc	18	10	the	the	DT
cord-327264-j0efi5vc	18	11	evidence	evidence	NN
cord-327264-j0efi5vc	18	12	around	around	IN
cord-327264-j0efi5vc	18	13	what	what	WP
cord-327264-j0efi5vc	18	14	is	be	VBZ
cord-327264-j0efi5vc	18	15	best	good	JJS
cord-327264-j0efi5vc	18	16	practice	practice	NN
cord-327264-j0efi5vc	18	17	in	in	IN
cord-327264-j0efi5vc	18	18	caring	care	VBG
cord-327264-j0efi5vc	18	19	for	for	IN
cord-327264-j0efi5vc	18	20	patients	patient	NNS
cord-327264-j0efi5vc	18	21	with	with	IN
cord-327264-j0efi5vc	18	22	respiratory	respiratory	JJ
cord-327264-j0efi5vc	18	23	infections	infection	NNS
cord-327264-j0efi5vc	18	24	and	and	CC
cord-327264-j0efi5vc	18	25	key	key	JJ
cord-327264-j0efi5vc	18	26	differences	difference	NNS
cord-327264-j0efi5vc	18	27	in	in	IN
cord-327264-j0efi5vc	18	28	respiratory	respiratory	JJ
cord-327264-j0efi5vc	18	29	pathogens	pathogen	NNS
cord-327264-j0efi5vc	18	30	in	in	IN
cord-327264-j0efi5vc	18	31	different	different	JJ
cord-327264-j0efi5vc	18	32	areas	area	NNS
cord-327264-j0efi5vc	18	33	of	of	IN
cord-327264-j0efi5vc	18	34	particular	particular	JJ
cord-327264-j0efi5vc	18	35	relevance	relevance	NN
cord-327264-j0efi5vc	18	36	to	to	IN
cord-327264-j0efi5vc	18	37	the	the	DT
cord-327264-j0efi5vc	18	38	Asia	Asia	NNP
cord-327264-j0efi5vc	18	39	-	-	HYPH
cord-327264-j0efi5vc	18	40	Pacific	Pacific	NNP
cord-327264-j0efi5vc	18	41	region	region	NN
cord-327264-j0efi5vc	18	42	.	.	.
cord-327264-j0efi5vc	19	1	I	-PRON-	PRP
cord-327264-j0efi5vc	19	2	hope	hope	VBP
cord-327264-j0efi5vc	19	3	readers	reader	NNS
cord-327264-j0efi5vc	19	4	of	of	IN
cord-327264-j0efi5vc	19	5	Respirology	Respirology	NNP
cord-327264-j0efi5vc	19	6	will	will	MD
cord-327264-j0efi5vc	19	7	find	find	VB
cord-327264-j0efi5vc	19	8	these	these	DT
cord-327264-j0efi5vc	19	9	reviews	review	NNS
cord-327264-j0efi5vc	19	10	a	a	DT
cord-327264-j0efi5vc	19	11	useful	useful	JJ
cord-327264-j0efi5vc	19	12	resource	resource	NN
cord-327264-j0efi5vc	19	13	clinically	clinically	RB
cord-327264-j0efi5vc	19	14	and	and	CC
cord-327264-j0efi5vc	19	15	an	an	DT
cord-327264-j0efi5vc	19	16	inspiration	inspiration	NN
cord-327264-j0efi5vc	19	17	to	to	TO
cord-327264-j0efi5vc	19	18	get	get	VB
cord-327264-j0efi5vc	19	19	involved	involve	VBN
cord-327264-j0efi5vc	19	20	in	in	IN
cord-327264-j0efi5vc	19	21	research	research	NN
cord-327264-j0efi5vc	19	22	as	as	IN
cord-327264-j0efi5vc	19	23	since	since	IN
cord-327264-j0efi5vc	19	24	the	the	DT
cord-327264-j0efi5vc	19	25	bugs	bug	NNS
cord-327264-j0efi5vc	19	26	will	will	MD
cord-327264-j0efi5vc	19	27	not	not	RB
cord-327264-j0efi5vc	19	28	stand	stand	VB
cord-327264-j0efi5vc	19	29	still	still	RB
cord-327264-j0efi5vc	19	30	,	,	,
cord-327264-j0efi5vc	19	31	neither	neither	CC
cord-327264-j0efi5vc	19	32	can	can	MD
cord-327264-j0efi5vc	19	33	we	-PRON-	PRP
cord-327264-j0efi5vc	19	34	!	!	.
cord-327264-j0efi5vc	20	1	Disclosure	disclosure	NN
cord-327264-j0efi5vc	20	2	statement	statement	NN
cord-327264-j0efi5vc	20	3	G.W.	G.W.	NNP
cord-327264-j0efi5vc	20	4	has	have	VBZ
cord-327264-j0efi5vc	20	5	been	be	VBN
cord-327264-j0efi5vc	20	6	paid	pay	VBN
cord-327264-j0efi5vc	20	7	to	to	TO
cord-327264-j0efi5vc	20	8	attend	attend	VB
cord-327264-j0efi5vc	20	9	advisory	advisory	JJ
cord-327264-j0efi5vc	20	10	boards	board	NNS
cord-327264-j0efi5vc	20	11	for	for	IN
cord-327264-j0efi5vc	20	12	Menarini	Menarini	NNP
cord-327264-j0efi5vc	20	13	Pharmaceuticals	Pharmaceuticals	NNP
cord-327264-j0efi5vc	20	14	.	.	.
cord-327264-j0efi5vc	21	1	School	School	NNP
cord-327264-j0efi5vc	21	2	of	of	IN
cord-327264-j0efi5vc	21	3	Medicine	Medicine	NNP
cord-327264-j0efi5vc	21	4	,	,	,
cord-327264-j0efi5vc	21	5	The	the	DT
cord-327264-j0efi5vc	21	6	University	University	NNP
cord-327264-j0efi5vc	21	7	of	of	IN
cord-327264-j0efi5vc	21	8	Western	Western	NNP
cord-327264-j0efi5vc	21	9	Australia	Australia	NNP
cord-327264-j0efi5vc	21	10	,	,	,
cord-327264-j0efi5vc	21	11	Perth	Perth	NNP
cord-327264-j0efi5vc	21	12	,	,	,
cord-327264-j0efi5vc	21	13	Western	Western	NNP
cord-327264-j0efi5vc	21	14	Australia	Australia	NNP
cord-327264-j0efi5vc	21	15	,	,	,
cord-327264-j0efi5vc	21	16	Australia	Australia	NNP
cord-327264-j0efi5vc	21	17	World	World	NNP
cord-327264-j0efi5vc	21	18	Health	Health	NNP
cord-327264-j0efi5vc	21	19	Organisation	Organisation	NNP
cord-327264-j0efi5vc	21	20	.	.	.
cord-327264-j0efi5vc	22	1	The	the	DT
cord-327264-j0efi5vc	22	2	top	top	JJ
cord-327264-j0efi5vc	22	3	10	10	CD
cord-327264-j0efi5vc	22	4	causes	cause	NNS
cord-327264-j0efi5vc	22	5	of	of	IN
cord-327264-j0efi5vc	22	6	death	death	NN
cord-327264-j0efi5vc	22	7	hospitalizations	hospitalization	NNS
cord-327264-j0efi5vc	22	8	for	for	IN
cord-327264-j0efi5vc	22	9	pneumonia	pneumonia	NN
cord-327264-j0efi5vc	22	10	after	after	IN
cord-327264-j0efi5vc	22	11	a	a	DT
cord-327264-j0efi5vc	22	12	decade	decade	NN
cord-327264-j0efi5vc	22	13	of	of	IN
cord-327264-j0efi5vc	22	14	pneumococcal	pneumococcal	JJ
cord-327264-j0efi5vc	22	15	vaccination	vaccination	NN
cord-327264-j0efi5vc	22	16	Effect	effect	NN
cord-327264-j0efi5vc	22	17	of	of	IN
cord-327264-j0efi5vc	22	18	high	high	JJ
cord-327264-j0efi5vc	22	19	-	-	HYPH
cord-327264-j0efi5vc	22	20	valency	valency	NN
cord-327264-j0efi5vc	22	21	pneumococcal	pneumococcal	JJ
cord-327264-j0efi5vc	22	22	conjugate	conjugate	NN
cord-327264-j0efi5vc	22	23	vaccines	vaccine	NNS
cord-327264-j0efi5vc	22	24	on	on	IN
cord-327264-j0efi5vc	22	25	invasive	invasive	JJ
cord-327264-j0efi5vc	22	26	pneumococcal	pneumococcal	JJ
cord-327264-j0efi5vc	22	27	disease	disease	NN
cord-327264-j0efi5vc	22	28	in	in	IN
cord-327264-j0efi5vc	22	29	children	child	NNS
cord-327264-j0efi5vc	22	30	in	in	IN
cord-327264-j0efi5vc	22	31	SpIDnet	spidnet	JJ
cord-327264-j0efi5vc	22	32	countries	country	NNS
cord-327264-j0efi5vc	23	1	:	:	:
cord-327264-j0efi5vc	23	2	an	an	DT
cord-327264-j0efi5vc	23	3	observational	observational	JJ
cord-327264-j0efi5vc	23	4	multicentre	multicentre	NNP
cord-327264-j0efi5vc	23	5	study	study	VB
cord-327264-j0efi5vc	23	6	The	the	DT
cord-327264-j0efi5vc	23	7	herd	herd	NN
cord-327264-j0efi5vc	23	8	effects	effect	NNS
cord-327264-j0efi5vc	23	9	of	of	IN
cord-327264-j0efi5vc	23	10	infant	infant	NN
cord-327264-j0efi5vc	23	11	PCV7	PCV7	NNP
cord-327264-j0efi5vc	23	12	/	/	SYM
cord-327264-j0efi5vc	23	13	PCV13	PCV13	NNP
cord-327264-j0efi5vc	23	14	sequential	sequential	JJ
cord-327264-j0efi5vc	23	15	implementation	implementation	NN
cord-327264-j0efi5vc	23	16	on	on	IN
cord-327264-j0efi5vc	23	17	adult	adult	NN
cord-327264-j0efi5vc	23	18	invasive	invasive	JJ
cord-327264-j0efi5vc	23	19	pneumococcal	pneumococcal	JJ
cord-327264-j0efi5vc	23	20	disease	disease	NN
cord-327264-j0efi5vc	23	21	,	,	,
cord-327264-j0efi5vc	23	22	six	six	CD
cord-327264-j0efi5vc	23	23	years	year	NNS
cord-327264-j0efi5vc	23	24	post	post	VBP
cord-327264-j0efi5vc	23	25	implementation	implementation	NN
cord-327264-j0efi5vc	23	26	;	;	:
cord-327264-j0efi5vc	23	27	a	a	DT
cord-327264-j0efi5vc	23	28	nationwide	nationwide	JJ
cord-327264-j0efi5vc	23	29	study	study	NN
cord-327264-j0efi5vc	23	30	in	in	IN
cord-327264-j0efi5vc	23	31	Israel	Israel	NNP
cord-327264-j0efi5vc	24	1	The	the	DT
cord-327264-j0efi5vc	24	2	rise	rise	NN
cord-327264-j0efi5vc	24	3	and	and	CC
cord-327264-j0efi5vc	24	4	fall	fall	NN
cord-327264-j0efi5vc	24	5	of	of	IN
cord-327264-j0efi5vc	24	6	pneumococcal	pneumococcal	JJ
cord-327264-j0efi5vc	24	7	serotypes	serotype	NNS
cord-327264-j0efi5vc	24	8	carried	carry	VBN
cord-327264-j0efi5vc	24	9	in	in	IN
cord-327264-j0efi5vc	24	10	the	the	DT
cord-327264-j0efi5vc	24	11	PCV	pcv	NN
cord-327264-j0efi5vc	24	12	era	era	NN